Fa-Chyi Lee
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 8
- Pancreatic and Hepatic Oncology Research 3
- Cancer Immunotherapy and Biomarkers 1
- Colorectal Cancer Surgical Treatments 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Co-authors
- Mohammad Houman Fekrazad (5 shared papers)Ian Rabinowitz (5 shared papers)Claire F. Verschraegen (4 shared papers)Donald Paul Bottaro (1 shared paper)James M. Ford (1 shared paper)Li Liu (1 shared paper)Howard Kallender (1 shared paper)Tona M. Gilmer (1 shared paper)
- Journals
- The Oncologist (3 papers)The Lancet (2 papers)Blood (1 paper)Clinical Colorectal Cancer (1 paper)Translational Oncology (1 paper)
- Partner nations
- United StatesTaiwanChina
In The Last Decade
Fa-Chyi Lee
29 papers receiving 1.9k citations
Fa-Chyi Lee's Hit Papers
Peers
Comparison fields: 5 of 53
- Hepatology 365
- Oncology 775
- Biomaterials 124
- Pulmonary and Respiratory Medicine 132
- Pharmacology 16
Countries citing papers authored by Fa-Chyi Lee
This map shows the geographic impact of Fa-Chyi Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fa-Chyi Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fa-Chyi Lee more than expected).
Fields of papers citing papers by Fa-Chyi Lee
This network shows the impact of papers produced by Fa-Chyi Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fa-Chyi Lee. The network helps show where Fa-Chyi Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Fa-Chyi Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial Hit paper breakdown → | 2015 | 951 |
| 2 | Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study Hit paper breakdown → | 2023 | 528 |
| 3 | 2013 | 183 | |
| 4 | 2010 | 46 | |
| 5 | 2018 | 46 | |
| 6 | 2014 | 29 | |
| 7 | 2017 | 27 | |
| 8 | 2022 | 20 | |
| 9 | 2010 | 17 | |
| 10 | 2017 | 16 | |
| 11 | 2021 | 14 | |
| 12 | 2010 | 12 | |
| 13 | 2010 | 9 | |
| 14 | 2002 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2019 | 8 | |
| 17 | 2014 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2002 | 5 | |
| 20 | 2017 | 5 |
About Fa-Chyi Lee
Fa-Chyi Lee is a scholar working on Oncology, Hepatology, Pharmacology, Genetics and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (3 papers), Epigenetics and DNA Methylation (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Economic and Financial Impacts of Cancer (1 paper), Glioma Diagnosis and Treatment (1 paper), Colorectal Cancer Surgical Treatments (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Hepatology (365 citations), Oncology (775 citations), Biomaterials (124 citations), Pulmonary and Respiratory Medicine (132 citations) and Pharmacology (16 citations). Fa-Chyi Lee has collaborated with scholars based in United States, Taiwan and China. Frequent co-authors include Mohammad Houman Fekrazad, Ian Rabinowitz, Claire F. Verschraegen, Donald Paul Bottaro, James M. Ford, Li Liu, Howard Kallender, Tona M. Gilmer, Harold N Keer and Manish A. Shah. Their work appears in journals such as The Oncologist, The Lancet, Blood, Clinical Colorectal Cancer and Translational Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.